Stockreport

Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study

CORIUM INTL  (CORI) 
Last corium intl earnings: 8/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.coriumgroup.com/investor-relations
PDF MENLO PARK, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development [Read more]